Share This Author
Melatonin in Psychiatric Disorders: A Review on the Melatonin Involvement in Psychiatry
- Claudia Pacchierotti, S. Iapichino, L. Bossini, F. Pieraccini, P. Castrogiovanni
- Psychology, MedicineFrontiers in Neuroendocrinology
- 31 January 2001
An understanding of the role of the pineal hormone and of its alterations in psychiatric diseases could help to identify the biological mechanisms underlying such disorders.
Dysfunctions of Cortical Excitability in Drug-Naïve Posttraumatic Stress Disorder Patients
Magnetic resonance imaging volumes of the hippocampus in drug-naïve patients with post-traumatic stress disorder without comorbidity conditions.
Attachment and Panic Disorder
- Claudia Pacchierotti, L. Bossini, A. Castrogiovanni, F. Pieraccini, I. Soreca, P. Castrogiovanni
- 1 November 2002
It was showed that DSM-III-R-diagnosed PD patients reported their parents to be significantly less caring than did the control group, while there was no significant difference in objective recall of parenting experiences.
Off-label uses of trazodone: a review
- L. Bossini, I. Casolaro, D. Koukouna, F. Cecchini, A. Fagiolini
- Psychology, MedicineExpert opinion on pharmacotherapy
- 18 July 2012
The possibility that a combination of trazodone with SSRIs may prevent or treat some of the SSRI side effects, such as anxiety, insomnia and sexual dysfunction, in addition to synergically increasing SSRI' antidepressant activity is discussed.
[Sexual dysfunctions, psychiatric diseases and quality of life: a review].
A review of recent literature highlights the correlation between dysfunction and a decreased quality of life in people with psychiatric comorbidity, and explores several aspects impacting care, from following the patient to pharmacological and non-pharmacological treatments.
Activity of Citalopram on Adenosine and Serotonin Circulating Levels in Depressed Patients
- P. Blardi, A. de Lalla, P. Castrogiovanni
- PsychologyJournal of clinical psychopharmacology
- 1 June 2005
Serotonin levels in platelets decreased after drug administration, reaching the lowest values on the last day of treatment, and citalopram, serotonin, and adenosine concentrations in plasma increased after citalsopram administration, and the highest levels were observed on theLast day of Treatment.
Changes in hippocampal volume in patients with post-traumatic stress disorder after sertraline treatment.
Evidence of diffuse damage in frontal and occipital cortex in the brain of patients with post-traumatic stress disorder
In drug-naïve PTSD patients with a history of adulthood trauma, brain structural damage is diffuse, with a particular prevalence for the frontal and occipital lobes, and is clinically relevant.